Header cover image

Egyptian (OMX) Pharma Industry Analysis

UpdatedApr 25, 2024
DataAggregated Company Financials
Companies11
  • 7D-7.8%
  • 3M1.7%
  • 1Y27.3%
  • YTD8.2%

In the last week, the Pharma industry is up 1.1%, with Arab Drug up 0.6%. During this same period, the Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E underperformed, falling 10%. This means that the industry has gained 32% over the past year. As for the next few years, earnings are expected to grow by 19% per annum.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 25 Apr 2024ج.م20.0bج.م19.3bج.م1.7b7.9x11.5x1x
Sat, 23 Mar 2024ج.م22.4bج.م19.2bج.م2.3b8.8x9.9x1.2x
Mon, 19 Feb 2024ج.م23.1bج.م18.5bج.م2.4b10.4x9.7x1.3x
Wed, 17 Jan 2024ج.م18.9bج.م16.4bج.م2.2b7.1x8.6x1.2x
Fri, 15 Dec 2023ج.م19.0bج.م16.5bج.م2.2b8.7x8.8x1.2x
Sun, 12 Nov 2023ج.م15.3bج.م15.4bج.م1.9b6.9x7.9x1x
Tue, 10 Oct 2023ج.م13.6bج.م15.3bج.م1.9b5.4x7.1x0.9x
Thu, 07 Sep 2023ج.م14.3bج.م15.9bج.م2.0b7.2x7x0.9x
Sat, 05 Aug 2023ج.م13.4bج.م15.6bج.م2.1b7.1x6.4x0.9x
Mon, 03 Jul 2023ج.م13.9bج.م15.6bج.م2.1b7.2x6.6x0.9x
Wed, 31 May 2023ج.م13.7bج.م16.0bج.م2.3b5.1x5.9x0.9x
Fri, 28 Apr 2023ج.م14.4bج.م16.2bج.م2.4b5.2x6x0.9x
Sun, 26 Mar 2023ج.م14.0bج.م15.7bج.م2.3b5.2x6.1x0.9x
Tue, 21 Feb 2023ج.م14.4bج.م15.7bج.م2.3b5.3x6.3x0.9x
Thu, 19 Jan 2023ج.م15.2bج.م15.6bج.م2.3b5.4x6.7x1x
Sat, 17 Dec 2022ج.م14.6bج.م15.6bج.م2.3b5.3x6.4x0.9x
Mon, 14 Nov 2022ج.م13.1bج.م15.1bج.م2.2b5.1x6x0.9x
Wed, 12 Oct 2022ج.م12.6bج.م15.1bج.م2.2b4.7x5.8x0.8x
Fri, 09 Sep 2022ج.م12.9bج.م14.3bج.م2.0b6.1x6.3x0.9x
Sun, 07 Aug 2022ج.م12.6bج.م14.1bج.م1.9b5.7x6.5x0.9x
Tue, 05 Jul 2022ج.م11.7bج.م14.1bج.م1.9b5.6x6.1x0.8x
Thu, 02 Jun 2022ج.م12.0bج.م12.0bج.م1.7b5.6x7x1x
Sat, 30 Apr 2022ج.م12.3bج.م11.9bج.م1.7b5.7x7.4x1x
Mon, 28 Mar 2022ج.م12.9bج.م13.7bج.م1.8b6.6x7x0.9x
Wed, 23 Feb 2022ج.م13.0bج.م13.4bج.م1.8b6.5x7.1x1x
Fri, 21 Jan 2022ج.م13.7bج.م13.3bج.م1.8b6.3x7.5x1x
Sun, 19 Dec 2021ج.م12.9bج.م13.3bج.م1.8b5.9x7.1x1x
Tue, 16 Nov 2021ج.م12.3bج.م13.1bج.م1.8b5.9x6.9x0.9x
Thu, 14 Oct 2021ج.م12.7bج.م12.9bج.م1.8b5.5x7.2x1x
Sat, 11 Sep 2021ج.م13.5bج.م13.0bج.م1.8b5.1x7.5x1x
Mon, 09 Aug 2021ج.م13.3bج.م13.0bج.م1.8b5.1x7.4x1x
Sun, 02 May 2021ج.م12.6bج.م12.6bج.م1.7b5.3x7.5x1x
Price to Earnings Ratio

7.5x


Total Market Cap: ج.م12.6bTotal Earnings: ج.م1.7bTotal Revenue: ج.م12.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Pharma Industry Price to Earnings3Y Average 7.2x202220232024
Current Industry PE
  • Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 12.1x which is higher than its 3-year average PE of 7.2x.
  • The 3-year average PS ratio of 0.97x is lower than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Egyptian Healthcare industry?

EG Market-11.47%
Healthcare-6.35%
Pharma-7.81%
Pharma-7.81%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ADCI Arab Drugج.م94.190.6%
+ج.م3.2m
57.1%PE7.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News